Theranos names execs to lead compliance, regulatory affairs | iNFOnews | Thompson-Okanagan's News Source

Current Conditions


Theranos names execs to lead compliance, regulatory affairs

July 21, 2016 - 7:24 AM

NEW YORK - Theranos Inc. named a new vice-president in charge of regulatory issues and a new chief compliance officer weeks after federal regulators banned the company's founder and CEO from owning or running a medical laboratory for two years.

The ban followed months of investigation by government testing regulators where they found a number of violations of federal testing standards at the blood-test company's site. The action followed stories by The Wall Street Journal in which former employees said the company's tests were unreliable.

Theranos named Dave Wurtz as vice-president of regulatory and quality and it named Daniel Guggenheim, as its chief compliance officer.

They report to CEO Elizabeth Holmes.

News from © The Associated Press, 2016
The Associated Press

  • Popular vernon News
View Site in: Desktop | Mobile